1beta,3beta,15alpha-trihydroxy-urs-9(11)-12-diene - Compound Card

1beta,3beta,15alpha-trihydroxy-urs-9(11)-12-diene

Select a section from the left sidebar

1beta,3beta,15alpha-trihydroxy-urs-9(11)-12-diene

Structure
Zoomed Structure
  • Family: Plantae - Lamiaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Ursene Triterpene
Canonical Smiles C[C@@H]1CC[C@]2([C@@H]([C@H]1C)C1=CC=C3[C@@]([C@@]1([C@H](C2)O)C)(C)CC[C@@H]1[C@]3(C)[C@H](O)C[C@@H](C1(C)C)O)C
InChI InChI=1S/C30H48O3/c1-17-11-13-27(5)16-24(33)30(8)19(25(27)18(17)2)9-10-21-28(30,6)14-12-20-26(3,4)22(31)15-23(32)29(20,21)7/h9-10,17-18,20,22-25,31-33H,11-16H2,1-8H3/t17-,18+,20+,22+,23-,24+,25+,27-,28-,29+,30+/m1/s1
InChIKey CTCOHAYTJYAGAT-OSIMVUHNSA-N
Formula C30H48O3
HBA 3
HBD 3
MW 456.71
Rotatable Bonds 0
TPSA 60.69
LogP 5.89
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 33
Formal Charge 0
Fraction CSP3 0.87
Exact Mass 456.36
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Salvia argentea Lamiaceae Plantae 49208

Showing of synonyms

  • Bechkri S, Alabdul Magid A, et al. (2019). Triterpenes from Salvia argentea var. aurasiaca and their antibacterial and cytotoxic activities.. Fitoterapia, 2019, 139, 104296. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(=CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 456.71 g/mol

Anti-alzheimer
Anti-hyperlipidemic
Anti-hypertensive
Anti-inflammatory
Antimicrobial
Antioxidant
Antipyretic
Antitumor
Expectorant
Hepatoprotective
Sedative
Spasmolytic

Absorption

Caco-2 (logPapp)
-4.74
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.62
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
-2.69

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
1.39
Plasma Protein Binding
85.93
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
11.76
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.4
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.81
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
6.1
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-82.64
Rat (Acute)
3.63
Rat (Chronic Oral)
2.04
Fathead Minnow
3.87
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
425.18
Hydration Free Energy
-2.74
Log(D) at pH=7.4
5.54
Log(P)
6.2
Log S
-5.55
Log(Vapor Pressure)
-8.63
Melting Point
211.99
pKa Acid
10.4
pKa Basic
6.97
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Fatty acid-binding protein 10-A, liver basic Q9I8L5 FA10A_DANRE Danio rerio 2 0.7450
3-ketosteroid dehydrogenase Q9RA02 Q9RA02_RHOER Rhodococcus erythropolis 2 0.7435

Download SDF